These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33881969)

  • 1. SARS-CoV-2 Entry Inhibitors Targeting Virus-ACE2 or Virus-TMPRSS2 Interactions.
    Lin H; Cherukupalli S; Feng D; Gao S; Kang D; Zhan P; Liu X
    Curr Med Chem; 2022; 29(4):682-699. PubMed ID: 33881969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.
    Muralidar S; Gopal G; Visaga Ambi S
    J Med Virol; 2021 Sep; 93(9):5260-5276. PubMed ID: 33851732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
    Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
    J Genet; 2021; 100(1):. PubMed ID: 33707363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of SARS-CoV-2 cell entry: insight from
    Gyebi GA; Adegunloye AP; Ibrahim IM; Ogunyemi OM; Afolabi SO; Ogunro OB
    J Biomol Struct Dyn; 2022 Mar; 40(5):2121-2145. PubMed ID: 33089728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
    Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
    J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model.
    Choi Y; Shin B; Kang K; Park S; Beck BR
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33218024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
    Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
    Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Transmembrane Protease Serine 2 (TMPRSS2) Non-Protease Domains Regulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike-Mediated Virus Entry.
    Strobelt R; Adler J; Shaul Y
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
    Xiang Y; Wang M; Chen H; Chen L
    Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
    Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
    J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
    Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
    Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral S protein histochemistry reveals few potential SARS-CoV-2 entry sites in human ocular tissues.
    Martin G; Wolf J; Lapp T; Agostini HT; Schlunck G; Auw-Hädrich C; Lange CAK
    Sci Rep; 2021 Sep; 11(1):19140. PubMed ID: 34580409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
    Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
    Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.
    Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L
    J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effects of toothpaste and mouthwash ingredients on the interaction between the SARS-CoV-2 spike protein and ACE2, and the protease activity of TMPRSS2 in vitro.
    Tateyama-Makino R; Abe-Yutori M; Iwamoto T; Tsutsumi K; Tsuji M; Morishita S; Kurita K; Yamamoto Y; Nishinaga E; Tsukinoki K
    PLoS One; 2021; 16(9):e0257705. PubMed ID: 34534255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.